Press Releases
15 March 2023
Acesion Pharma the biotech pioneering first-in-class novel therapies for Atrial Fibrillation the most common cardiac arrhythmia, today announced positive data from its Phase 2 trial of AP30663, a first-in-class SK ion channel inhibitor for conversion of AF to normal sinus rhythm. The trial enrolled 63 patients with a current episode of AF and tested two intravenous doses of AP30663, 3 and 5 mg/kg, compared to placebo. The primary endpoint was the proportion of patients with AF conve
Read more...Bryn Pharma LLC, a privately held pharmaceutical company dedicated to finding a better way for patients and caregivers to treat anaphylaxis, announced today that pharmaceutical industry veteran Sandy Loreaux has been appointed CEO, effective immediately. David Dworaczyk, Ph.D., is transitioning from the CEO role and will stay on as a senior advisor and head of R&D, Regulatory, and production efforts as Bryn works toward the completion and filing of the NDA for the company’s lead can
Read more...BIOCORP, a French company specialized in the design, development, and manufacturing of innovative medical devices, announced today the signature of a contract with HRA Pharma. This agreement concerns the development and industrialization of an innovative medical device aiming to provide instant relief and faster healing of skin injuries. After an initial concept and feasibility study conducted by BIOCORP, the two parties entered into an initial development agreement to design, test
Read more...13 March 2023
LEO Pharma, a global leader in medical dermatology, and ICON plc today announced a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective, and which will support the company’s overall ambition of building one of the most effective and efficient clinical portfolio execution organisations in the industry. The mission of the partnership is to improve the lives of dermatology patients with access to innovative
Read more...13 March 2023
Tokyo -based NIPPON EXPRESS HOLDINGS, INC.has compiled the "NX-Pharma Global Quality Manual", applicable effective Sunday, January 1, 2023, to unify and standardize pharmaceutical logistics quality standards globally. Logo : https://kyodonewsprwire.jp/img/202303013462-O1-7reh962D Image : NX-Pharma Global Quality Manual https://kyodonewsprwire.jp/prwfile/release/M103866/202303013462/_prw_PI2fl_yksd5VnD.webp The Nippon Express Group has positioned
Read more...Alnylam Pharmaceuticals, Inc. the leading RNAi therapeutics company, and Medison Pharma a global pharma company focused on providing access to highly innovative therapies for patients in international markets, have announced an expansion of their existing partnership to a multi-regional agreement that includes Poland, Czech Republic, Hungary, Slovakia, Lithuania, Estonia and Latvia, in addition to Israel. This new agreement builds upon the successful long-term partnership between Al
Read more...Fujirebio Holdings Inc., its wholly owned subsidiary Fujirebio Diagnostics Inc. and AriBio Co. Ltd announced that they have formed a strategic partnership to advance the development of biomarkers Alzheimer's disease and other neurodegenerative diseases. The agreement allows Fujirebio to access clinical samples and data collected in the ongoing Phase 3 study in Alzheimer's disease launched in December 2022 by AriBio. AriBio completed in 2021 a Phase 2 study in patients with m
Read more...In a joint effort to accelerate high-quality therapies to market, Nucleus Biologics, The Cell Performance Company™, a leading provider of custom cell culture media solutions for the cell and gene therapy industry, and Stoic Bio, a provider of sustainable technology for cell media manufacturing, have announced plans for a supply agreement with the Center for Breakthrough Medicines (CBM), a leading contract development and manufacturing organization (CDMO), whose mission is to save lives
Read more...NovaBay® Pharmaceuticals, Inc. announces the launch of OTC Avenova Eye Health Support oral supplement featuring a combination of MaquiBright®, a nutrient-rich, antioxidant-dense extract of the superfruit maqui berry, and high quality, natural triglyceride omega-3 oils to comfort dry eyes and support overall eye health. Avenova Eye Health Support is sold as 60 easy-to-swallow softgel capsules (30-day supply) and is available at Amazon.com and Avenova.com for $41.95, and throu
Read more...7 March 2023
Adial Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided an update on its regulatory strategy for AD04, the Company’s lead compound for the treatment of Alcohol Use Disorder . Key highlights: Additional analysis of ONWARD™ data identified specific genotypes that outperformed others Type C meeting w
Read more...